Follow
Joe Lennerz
Joe Lennerz
Massachusetts General Hospital/Harvard Medical School
Verified email at partners.org
Title
Cited by
Cited by
Year
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
K Cadwell, JY Liu, SL Brown, H Miyoshi, J Loh, JK Lennerz, C Kishi, W Kc, ...
Nature 456 (7219), 259-263, 2008
17572008
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
M Cella, A Fuchs, W Vermi, F Facchetti, K Otero, JKM Lennerz, ...
Nature 457 (7230), 722-725, 2009
15032009
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ...
Cancer discovery 6 (10), 1118-1133, 2016
11552016
COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ...
Cell 184 (2), 476-488. e11, 2021
7012021
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background
D Mitra, X Luo, A Morgan, J Wang, MP Hoang, J Lo, CR Guerrero, ...
Nature 491 (7424), 449-453, 2012
5772012
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
L Goyal, SK Saha, LY Liu, G Siravegna, I Leshchiner, LG Ahronian, ...
Cancer discovery 7 (3), 252-263, 2017
495*2017
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
JK Lennerz, EL Kwak, A Ackerman, M Michael, SB Fox, K Bergethon, ...
Journal of clinical oncology 29 (36), 4803-4810, 2011
4882011
Origins of lymphatic and distant metastases in human colorectal cancer
K Naxerova, JG Reiter, E Brachtel, JK Lennerz, M Van De Wetering, ...
Science 357 (6346), 55-60, 2017
4402017
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for …
Z Piotrowska, H Isozaki, JK Lennerz, JF Gainor, IT Lennes, VW Zhu, ...
Cancer discovery 8 (12), 1529-1539, 2018
4012018
Integrated molecular characterization of testicular germ cell tumors
H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ...
Cell reports 23 (11), 3392-3406, 2018
3852018
H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway
M Eberhardt, M Dux, B Namer, J Miljkovic, N Cordasic, C Will, TI Kichko, ...
Nature communications 5 (1), 4381, 2014
3772014
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications
D Dias-Santagata, Q Lam, K Vernovsky, N Vena, JK Lennerz, DR Borger, ...
PloS one 6 (3), e17948, 2011
3712011
Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular …
JK Lennerz, V Rühle, EP Ceppa, WL Neuhuber, NW Bunnett, EF Grady, ...
Journal of Comparative Neurology 507 (3), 1277-1299, 2008
3662008
Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK …
N Tanaka, JJ Lin, C Li, MB Ryan, J Zhang, LA Kiedrowski, AG Michel, ...
Cancer discovery 11 (8), 1913-1922, 2021
3352021
TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma
L Goyal, L Shi, LY Liu, F Fece de la Cruz, JK Lennerz, S Raghavan, ...
Cancer discovery 9 (8), 1064-1079, 2019
3052019
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
2922015
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
S Yoda, JJ Lin, MS Lawrence, BJ Burke, L Friboulet, A Langenbucher, ...
Cancer discovery 8 (6), 714-729, 2018
2892018
Test performance evaluation of SARS-CoV-2 serological assays
JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ...
Nature biotechnology 38 (10), 1174, 2020
2672020
Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system
K Zimmermann, JK Lennerz, A Hein, AS Link, JS Kaczmarek, M Delling, ...
Proceedings of the National Academy of Sciences 108 (44), 18114-18119, 2011
2602011
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ...
Nature biotechnology 38 (10), 1174-1183, 2020
2562020
The system can't perform the operation now. Try again later.
Articles 1–20